rs4760600

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033124.5(DRC2):​c.1223A>G​(p.Tyr408Cys) variant causes a missense change. The variant allele was found at a frequency of 0.37 in 1,613,700 control chromosomes in the GnomAD database, including 115,214 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.33 ( 9105 hom., cov: 31)
Exomes 𝑓: 0.37 ( 106109 hom. )

Consequence

DRC2
NM_033124.5 missense

Scores

1
8
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.97

Publications

40 publications found
Variant links:
Genes affected
DRC2 (HGNC:29937): (coiled-coil domain containing 65) This gene encodes a sperm tail protein that is highly expressed in adult testis, spermatocytes and spermatids. The protein plays a critical role in the assembly of the nexin-dynein regulatory complex. Mutations in this gene result in primary ciliary dyskinesia. [provided by RefSeq, Nov 2013]
DRC2 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 27
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031661987).
BP6
Variant 12-48921211-A-G is Benign according to our data. Variant chr12-48921211-A-G is described in ClinVar as Benign. ClinVar VariationId is 402504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC2NM_033124.5 linkc.1223A>G p.Tyr408Cys missense_variant Exon 8 of 8 ENST00000320516.5 NP_149115.2 Q8IXS2-1
DRC2NM_001286957.2 linkc.794A>G p.Tyr265Cys missense_variant Exon 8 of 8 NP_001273886.1 B4DXQ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC65ENST00000320516.5 linkc.1223A>G p.Tyr408Cys missense_variant Exon 8 of 8 1 NM_033124.5 ENSP00000312706.4 Q8IXS2-1
ENSG00000272822ENST00000398092.4 linkc.385-17303T>C intron_variant Intron 4 of 4 3 ENSP00000438507.1 F5H423

Frequencies

GnomAD3 genomes
AF:
0.326
AC:
49528
AN:
151948
Hom.:
9098
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.474
Gnomad ASJ
AF:
0.435
Gnomad EAS
AF:
0.465
Gnomad SAS
AF:
0.222
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.399
Gnomad NFE
AF:
0.377
Gnomad OTH
AF:
0.357
GnomAD2 exomes
AF:
0.382
AC:
95798
AN:
251020
AF XY:
0.373
show subpopulations
Gnomad AFR exome
AF:
0.149
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.438
Gnomad EAS exome
AF:
0.466
Gnomad FIN exome
AF:
0.383
Gnomad NFE exome
AF:
0.387
Gnomad OTH exome
AF:
0.389
GnomAD4 exome
AF:
0.375
AC:
547957
AN:
1461636
Hom.:
106109
Cov.:
49
AF XY:
0.371
AC XY:
270029
AN XY:
727120
show subpopulations
African (AFR)
AF:
0.151
AC:
5054
AN:
33480
American (AMR)
AF:
0.538
AC:
24057
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.432
AC:
11278
AN:
26134
East Asian (EAS)
AF:
0.474
AC:
18814
AN:
39700
South Asian (SAS)
AF:
0.224
AC:
19325
AN:
86256
European-Finnish (FIN)
AF:
0.387
AC:
20642
AN:
53392
Middle Eastern (MID)
AF:
0.377
AC:
2174
AN:
5768
European-Non Finnish (NFE)
AF:
0.382
AC:
424507
AN:
1111834
Other (OTH)
AF:
0.366
AC:
22106
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
19331
38661
57992
77322
96653
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13228
26456
39684
52912
66140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.326
AC:
49545
AN:
152064
Hom.:
9105
Cov.:
31
AF XY:
0.329
AC XY:
24482
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.157
AC:
6515
AN:
41518
American (AMR)
AF:
0.474
AC:
7239
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.435
AC:
1509
AN:
3470
East Asian (EAS)
AF:
0.465
AC:
2401
AN:
5158
South Asian (SAS)
AF:
0.221
AC:
1065
AN:
4820
European-Finnish (FIN)
AF:
0.373
AC:
3933
AN:
10558
Middle Eastern (MID)
AF:
0.398
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
0.377
AC:
25614
AN:
67960
Other (OTH)
AF:
0.359
AC:
757
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1668
3337
5005
6674
8342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.374
Hom.:
53302
Bravo
AF:
0.337
TwinsUK
AF:
0.374
AC:
1386
ALSPAC
AF:
0.375
AC:
1444
ESP6500AA
AF:
0.158
AC:
695
ESP6500EA
AF:
0.382
AC:
3287
ExAC
AF:
0.369
AC:
44788
Asia WGS
AF:
0.358
AC:
1243
AN:
3478
EpiCase
AF:
0.389
EpiControl
AF:
0.392

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 27 Benign:2
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.29
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
.;.;T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.92
D;D;D
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
4.0
PrimateAI
Uncertain
0.66
T
PROVEAN
Pathogenic
-7.9
D;D;D
REVEL
Benign
0.15
Sift
Uncertain
0.0020
D;D;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.26
MPC
0.36
ClinPred
0.038
T
GERP RS
4.5
Varity_R
0.62
gMVP
0.72
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4760600; hg19: chr12-49314994; COSMIC: COSV56739607; COSMIC: COSV56739607; API